A phase 1 trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake Journal Articles Refereed uri icon

Overview

Start page

  • 4810

End page

  • 4817

Published in

  • Clinical Cancer Research

Time

Date/time value

  • 2005

Identity

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-04-2329

Additional Document Info

Volume

  • 11

Issue

  • 13

Publisher

  • American Association for Cancer Research
  • External Links
    • Digital Object Identifier
    •  
    • Google Scholar
    • Microsoft Academic Search
    • Mendeley
    • University login required

Melbourne Research

Level 5, 161 Barry Street
The University of Melbourne
Parkville 3010 VIC Australia

  • Authoriser:
    Deputy Vice-Chancellor (Research)
  • Maintainer:
    Research Marketing Manager